Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factor.
Savarese DM, Denicoff AM, Berg SL, Hillig M, Baker SP, O'Shaughnessy JA, Chow C, Otterson GA, Balis FM, Poplack DG, et al.
Savarese DM, et al.
J Clin Oncol. 1993 Sep;11(9):1795-803. doi: 10.1200/JCO.1993.11.9.1795.
J Clin Oncol. 1993.
PMID: 7689093
Clinical Trial.